Drugs Made In America Acquisition Corp.

This company is a special-purpose acquisition company (SPAC) incorporated in the Cayman Islands that was formed to identify, acquire, and grow businesses in artificial intelligence, pharmaceuticals, and other innovation-driven sectors through merger or asset acquisition. The company raised approximately $230 million in gross proceeds from its initial public offering and subsequent offerings, with these funds held in trust for completing a qualifying business combination that meets specified criteria including proven leadership, sustainable cash flow generation, and valuation discipline. The company operates as a blank-check vehicle seeking to partner target businesses with its team's expertise and industry networks to drive value creation, with strict governance rights and redemption provisions protecting public shareholders, including the ability to redeem shares at their pro-rata trust value if no business combination is consummated within the prescribed timeframe.